FDA Unveils Proposal For Streamlined De Novo Reviews
Despite statutory constraints, FDA is hoping to trim as many as 90 days off the total review process for de novo petitions.
Despite statutory constraints, FDA is hoping to trim as many as 90 days off the total review process for de novo petitions.